News

Occlutech announced that it has successfully obtained a ruling by the U.K. Patents Court in the High Court of Justice in London that invalidates AGA/St Jude's patent —EP0957773B1 in the United...

August 1, 2014 — The U.S. Department of Health and Human Services (HHS) issued a rule today finalizing Oct. 1, 2015, as the new compliance date for healthcare providers, health plans,...

August 1, 2014 — MedXT, a cloud platform provider for medical imaging, launched a cost-effective cloud-based, mobile solution cleared by the U.S. Food and Drug Administration (FDA).

STEMI, inaccurate ECG reads

In a community hospital and emergency medical services (EMS) system, the standard 12-lead electrocardiogram (ECG) is the primary and initial objective diagnostic tool used by emergency medical...

July 31, 2014 — Radiation therapy may offer a promising new noninvasive alternative treatment for the millions of Americans whose high blood pressure doesn’t respond to medication, suggests...

 Corindus Vascular Robotics CorPath Installations Robotic Systems Cath Lab

As attention increases on the effects of radiation exposure among interventional cardiologists[1], Corindus Vascular Robotics announced the recent installations of its CorPath System at five...

Cardio Ox investigation Astronaut Oxidative Stress Cardiovascular Health

The heart of an astronaut is a much-studied thing. Scientists have analyzed its blood flow, rhythms, atrophy and, through journal studies, even matters of the heart. 

July 30, 2014 — New research from Penn Medicine shows that incisionless transcatheter aortic valve replacement (TAVR) surgery cuts lengths of hospital stay by 30 percent and has no impact on post-...

July 30, 2014 — OrbusNeich announced the first patient has been enrolled in the Multinational Abluminal Sirolimus Coated BiO-Engineered StenT (MASCOT) post-marketing registry. The first Combo dual...

The American Society of Echocardiography Education and Research Foundation (ASEF) announced that it will host Value-Based Healthcare: Summit 2014, Friday, Sept. 12, 2014, in Washington, D.C., at...

CardioVascular Institute Clinical Trial Heart Failure Treatment Parachute

Following a heart attack, many heart failure patients suffer from enlargement of their left ventricle, diminishing the amount of blood the heart can pump to the body and resulting in life-...

July 30, 2014 — Covidien announced the commercial launch of its next-generation Trellis peripheral infusion system. The redesigned system continues to be the only pharmacomechanical thrombolysis...

July 30, 2014 — St. Jude Medical announced CE mark approval and first use of the FlexAbility ablation catheter, a novel ablation technology used by electrophysiologists (EPs) for the treatment of...

July 30, 2014 — Regado Biosciences announced earlier this month it has voluntarily paused enrollment in its REGULATE-PCI trial, which was testing the safety and effectiveness of its Revolixys...

MitraClip Abbott Vascular Heart Valve Repair University of Alabama at Birmingham

Mary York knew the walk from the living room to the bedroom should not have been difficult for her husband, Bill, despite his age, but the 83-year-old could not walk anywhere in his house without...

Biotronik BIOLUX 4Ever Clinical Trial Pulsar-18 SES Passeo-18 Lux DRB PAD Cath

Biotronik announced that the first patient has been enrolled in the investigator-initiated BIOLUX 4EVER trial. 

CT myocardial perfusion

The key take away message from the Society of Cardiovascular Computed Tomography (SCCT) annual meeting in July was that CT technology is advancing rapidly and there is a strong feeling it will...

Boston Scientific Corp. CE mark Ranger Ranger Paclitaxel-coated PTA Balloon Cath

Boston Scientific received CE mark for the Ranger Paclitaxel-coated PTA Balloon Catheter. The technology is now in full European market launch. 

Robert Smith, a cardiologist at Saint Francis Hospital and Medical Center in Hartford, Conn., released the results of his retrospective study designed to compare single in-office automated blood...

cormatrix, cardiovascular, cardiovascular repair

CorMatrix Cardiovascular announced that it has received U.S. Food and Drug Administration (FDA) clearance to market the CorMatrix ECM for Vascular Repair.